Qianwei Ye
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The role of FK506-binding protein 12 in cancer: from biology to clinical application.
Journal: International immunopharmacology
Published: August 05, 2025
Beyond metabolism: exploring the regulatory and therapeutic implications of lactate and lactylation in cancer-regulated cell death.
Journal: Cell death & disease
Published: April 27, 2025
A Novel tRF, HCETSR, Derived From tRNA-Glu/TTC, Inhibits HCC Malignancy by Regulating the SPBTN1-catenin Complex Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 19, 2024
Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis.
Journal: Cell death discovery
Published: February 14, 2024
Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma.
Journal: MedComm
Published: June 07, 2023
Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on It.
Journal: Cell death discovery
Published: January 16, 2023
E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: March 16, 2022
"Sweet tooth"-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy.
Journal: Journal of materials chemistry. B
Published: March 10, 2021
Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 10, 2021
Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 10, 2020
Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria.
Journal: Annals of translational medicine
Published: March 17, 2020
Last Updated: 09/26/2026